1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Industry in Australia Market Research & Statistics

Therapy Industry in Australia Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 1 300 reports

Download Unlimited Documents from Trusted Public Sources

Therapy and Anti-Infective Market in Australia

  • June 2016
    7 pages
  • Therapy  

    Anti-Infective  

    Infectious Dise...  

  • Australia  

View report >

Therapy Market in Australia

  • June 2016
    23 pages
  • Therapy  

  • Australia  

View report >

Therapy Market in Australia

  • June 2016
    9 pages
  • Vaccine  

  • Australia  

View report >

Therapy Market in Australia

  • June 2016
    20 pages
  • Therapy  

    OTC  

  • Australia  

View report >

Therapy and Anti-Infective Market in Switzerland and Australia

  • May 2016
    6 pages
  • Therapy  

    Anti-Infective  

  • Switzerland  

    Australia  

View report >

Global Therapy Market

  • May 2016
    21 pages
  • Vaccine  

  • Australia  

    World  

    United States  

View report >

Therapy Market in New Zealand and Australia - Forecast

  • May 2016
    32 pages
  • Therapy  

  • New Zealand  

    Australia  

View report >

Therapy Market in Australia - Forecast

  • May 2016
    9 pages
  • Therapy  

  • Australia  

View report >

Therapy Market in Australia

  • May 2016
    108 pages
  • Therapy  

    Chemotherapy  

  • Australia  

View report >

Therapy Market in Australia

  • May 2016
    13 pages
  • Therapy  

  • Australia  

View report >


70 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 4 995)

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • $ 4 995
  • Industry report
  • May 2016
  • by GBI Research

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Non-Small Cell Lung Cancer (NSCLC) is ...

2016-2020 Australia Clinical Chemistry And Immunodiagno ...

May 2016 $ 2 450

Australia Cardiac Rhythm Management (crm) Procedures Ou ...

April 2016 $ 1 000

Factor Therapeutics Ltd. (australia)

May 2016 $ 950

Specialised Therapeutics Australia Pty. Ltd. - Pharmace ...

May 2016 $ 250

Circadian Technologies Limited – Mergers & Acquisitio ...

March 2016 $ 350

Aspen Pharmacare Holdings Limited – Mergers & Acquisi ...

March 2016 $ 350

Arana Therapeutics Limited (formerly Peptech Limited) ...

March 2016 $ 350

Mesoblast Limited – Mergers & Acquisitions (m&a), Par ...

March 2016 $ 350

Cephalon International Holdings, Inc. – Mergers & Acq ...

March 2016 $ 350

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.